DCF — ATRIUM HEALTH CABARRUS
Enterprise Value: $952.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$952.8M
Enterprise Value
$261.7M
PV of Cash Flows
$691.1M
PV of Terminal Value
$1.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $781.7M | $112.6M | 14.0% | $56.2M | $51.1M |
| Year 2 | $805.2M | $124.0M | 15.0% | $64.0M | $52.9M |
| Year 3 | $829.3M | $136.0M | 16.0% | $72.1M | $54.2M |
| Year 4 | $854.2M | $144.4M | 17.0% | $77.5M | $52.9M |
| Year 5 | $879.8M | $150.9M | 17.0% | $81.4M | $50.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $952.8M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$758.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.1390365301728663
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5